内分泌肿瘤-话题@MedSci

#内分泌肿瘤#

88篇内容 | 3239人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1763486, encodeId=3d861e634868e, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V2）, objectType=article, longId=137718, objectId=067613e718ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=067613e718ce, replyNumber=0, likeNumber=85, createdTime=2018-08-01, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=067613e718ce, moduleTitle=NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=067613e718ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763492, encodeId=18741e634929d, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=CLIN CANCER RES：SSA联合PRRT治疗晚期胃肠胰神经内分泌肿瘤患者, objectType=article, longId=151609, objectId=010015160985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=010015160985, replyNumber=0, likeNumber=88, createdTime=2019-02-28, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=010015160985, moduleTitle=CLIN CANCER RES：SSA联合PRRT治疗晚期胃肠胰神经内分泌肿瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=010015160985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763487, encodeId=bd971e634875d, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=2018共识文件：胃肠胰腺神经内分泌肿瘤的进展以及治疗反应标准, objectType=article, longId=138717, objectId=2242138e17b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2242138e17b4, replyNumber=0, likeNumber=40, createdTime=2019-01-11, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2242138e17b4, moduleTitle=2018共识文件：胃肠胰腺神经内分泌肿瘤的进展以及治疗反应标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2242138e17b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763489, encodeId=18731e63489ed, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Gastroenterology：二甲双胍与依维莫司和/或生长抑素类似物在胰腺内分泌肿瘤的治疗中无明显作用, objectType=article, longId=147959, objectId=4f3714e959c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f3714e959c0, replyNumber=0, likeNumber=74, createdTime=2019-06-23, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f3714e959c0, moduleTitle=Gastroenterology：二甲双胍与依维莫司和/或生长抑素类似物在胰腺内分泌肿瘤的治疗中无明显作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f3714e959c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763494, encodeId=ecd91e63494d0, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=DDS：简单血管结构分类可以预测胰腺神经内分泌肿瘤分级和预后, objectType=article, longId=153965, objectId=8a4f1539652a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a4f1539652a, replyNumber=0, likeNumber=104, createdTime=2019-02-28, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a4f1539652a, moduleTitle=DDS：简单血管结构分类可以预测胰腺神经内分泌肿瘤分级和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a4f1539652a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763491, encodeId=30bf1e63491bb, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V3）, objectType=article, longId=149043, objectId=48a714904369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48a714904369, replyNumber=0, likeNumber=45, createdTime=2018-11-13, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48a714904369, moduleTitle=NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48a714904369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763483, encodeId=28cb1e634835c, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, objectType=article, longId=128054, objectId=039a12805491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039a12805491, replyNumber=0, likeNumber=104, createdTime=2018-02-01, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039a12805491, moduleTitle=Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039a12805491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763482, encodeId=4a791e634824a, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Eur Radiol：一招制敌--ADC值鉴别胰腺神经内分泌肿瘤与胰腺内异位副脾！, objectType=article, longId=121581, objectId=e58812158195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e58812158195, replyNumber=0, likeNumber=89, createdTime=2018-03-14, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e58812158195, moduleTitle=Eur Radiol：一招制敌--ADC值鉴别胰腺神经内分泌肿瘤与胰腺内异位副脾！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e58812158195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763479, encodeId=57be1e634794d, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JCEM：MEN1型中胰腺神经内分泌肿瘤自然进程如何？, objectType=article, longId=107951, objectId=811010e951fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=811010e951fd, replyNumber=0, likeNumber=144, createdTime=2018-06-08, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=811010e951fd, moduleTitle=JCEM：MEN1型中胰腺神经内分泌肿瘤自然进程如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=811010e951fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763484, encodeId=73f61e63484ef, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JCEM：多发性内分泌肿瘤1型患者的生活质量如何？, objectType=article, longId=134210, objectId=4f7213421059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f7213421059, replyNumber=0, likeNumber=98, createdTime=2018-09-14, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f7213421059, moduleTitle=JCEM：多发性内分泌肿瘤1型患者的生活质量如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f7213421059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763481, encodeId=08181e63481dc, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JCEM：垂体神经内分泌肿瘤可根据复发的危险性分为五级, objectType=article, longId=118297, objectId=259411829eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259411829eae, replyNumber=0, likeNumber=85, createdTime=2018-01-09, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259411829eae, moduleTitle=JCEM：垂体神经内分泌肿瘤可根据复发的危险性分为五级, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=259411829eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763485, encodeId=08011e63485c2, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V1）, objectType=article, longId=135325, objectId=6a56135325f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a56135325f1, replyNumber=0, likeNumber=43, createdTime=2019-01-05, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a56135325f1, moduleTitle=NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a56135325f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763478, encodeId=60921e63478b1, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=肺神经内分泌肿瘤病理诊断共识, objectType=article, longId=107868, objectId=856e10e868eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=856e10e868eb, replyNumber=0, likeNumber=58, createdTime=2017-12-18, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=856e10e868eb, moduleTitle=肺神经内分泌肿瘤病理诊断共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=856e10e868eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763477, encodeId=b9711e6347777, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Oncotarget：手术切除有利于胰腺神经内分泌肿瘤患者生存！, objectType=article, longId=107628, objectId=b24e10e628bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b24e10e628bb, replyNumber=0, likeNumber=105, createdTime=2017-08-20, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b24e10e628bb, moduleTitle=Oncotarget：手术切除有利于胰腺神经内分泌肿瘤患者生存！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b24e10e628bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763480, encodeId=a02f1e634805b, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Lancet oncol：用依维莫司治疗的晚期胃肠或肺神经内分泌肿瘤患者的生活质量。, objectType=article, longId=110563, objectId=ad9f11056368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9f11056368, replyNumber=0, likeNumber=114, createdTime=2017-09-10, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9f11056368, moduleTitle=Lancet oncol：用依维莫司治疗的晚期胃肠或肺神经内分泌肿瘤患者的生活质量。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9f11056368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763476, encodeId=99031e63476a6, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JCEM：根据复发的危险性，垂体神经内分泌肿瘤可分为五级（前瞻性研究）, objectType=article, longId=104248, objectId=3d8110424823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d8110424823, replyNumber=0, likeNumber=135, createdTime=2017-10-06, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d8110424823, moduleTitle=JCEM：根据复发的危险性，垂体神经内分泌肿瘤可分为五级（前瞻性研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d8110424823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763470, encodeId=b4a01e6347015, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=Br J Surg：无症状、零星发生、小无功能性胰腺神经内分泌肿瘤，积极监测即可, objectType=article, longId=80469, objectId=5d63804696b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d63804696b, replyNumber=0, likeNumber=131, createdTime=2017-04-28, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d63804696b, moduleTitle=Br J Surg：无症状、零星发生、小无功能性胰腺神经内分泌肿瘤，积极监测即可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d63804696b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763462, encodeId=52491e6346281, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=FDA批准Netspot用于罕见神经内分泌肿瘤的检测, objectType=article, longId=69841, objectId=3e0f69841be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e0f69841be, replyNumber=0, likeNumber=92, createdTime=2016-07-11, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e0f69841be, moduleTitle=FDA批准Netspot用于罕见神经内分泌肿瘤的检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e0f69841be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763468, encodeId=38171e634684a, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=JCO：依维莫司治疗晚期胰腺神经内分泌肿瘤（RADIANT-3）, objectType=article, longId=77522, objectId=aed4e752228, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aed4e752228, replyNumber=0, likeNumber=82, createdTime=2017-07-07, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aed4e752228, moduleTitle=JCO：依维莫司治疗晚期胰腺神经内分泌肿瘤（RADIANT-3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aed4e752228)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763471, encodeId=f37b1e63471a6, content=<a href='/topic/show?id=3fc83035361' target=_blank style='color:#2F92EE;'>#内分泌肿瘤#</a>, objectTitle=【盘点】2016“神经内分泌肿瘤”亮点研究汇总, objectType=article, longId=80964, objectId=059280964c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=059280964c0, replyNumber=0, likeNumber=92, createdTime=2017-04-02, rootId=0, userName=1249898am27暂无昵称, userId=763a37536718, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=059280964c0, moduleTitle=【盘点】2016“神经内分泌肿瘤”亮点研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=059280964c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

内分泌肿瘤

2020-05-29

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V2）

2018-08-01

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

CLIN CANCER RES：SSA联合PRRT治疗晚期胃肠胰神经内分泌肿瘤患者

2019-02-28

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

2018共识文件：胃肠胰腺神经内分泌肿瘤的进展以及治疗反应标准

2019-01-11

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Gastroenterology：二甲双胍与依维莫司和/或生长抑素类似物在胰腺内分泌肿瘤的治疗中无明显作用

2019-06-23

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

DDS：简单血管结构分类可以预测胰腺神经内分泌肿瘤分级和预后

2019-02-28

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V3）

2018-11-13

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗

2018-02-01

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Eur Radiol：一招制敌--ADC值鉴别胰腺神经内分泌肿瘤与胰腺内异位副脾！

2018-03-14

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JCEM：MEN1型中胰腺神经内分泌肿瘤自然进程如何？

2018-06-08

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JCEM：多发性内分泌肿瘤1型患者的生活质量如何？

2018-09-14

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JCEM：垂体神经内分泌肿瘤可根据复发的危险性分为五级

2018-01-09

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

NCCN临床实践指南：神经内分泌肿瘤和肾上腺瘤（2018.V1）

2019-01-05

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

肺神经内分泌肿瘤病理诊断共识

2017-12-18

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Oncotarget：手术切除有利于胰腺神经内分泌肿瘤患者生存！

2017-08-20

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Lancet oncol：用依维莫司治疗的晚期胃肠或肺神经内分泌肿瘤患者的生活质量。

2017-09-10

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JCEM：根据复发的危险性，垂体神经内分泌肿瘤可分为五级（前瞻性研究）

2017-10-06

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

Br J Surg：无症状、零星发生、小无功能性胰腺神经内分泌肿瘤，积极监测即可

2017-04-28

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

FDA批准Netspot用于罕见神经内分泌肿瘤的检测

2016-07-11

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

JCO：依维莫司治疗晚期胰腺神经内分泌肿瘤（RADIANT-3）

2017-07-07

1249898am27暂无昵称 (审核中...)

前往app查看评论内容

#内分泌肿瘤#

【盘点】2016“神经内分泌肿瘤”亮点研究汇总

2017-04-02

科室
- - 订阅+
  - 更多科室
工具
服务